Clinical trial
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin…
NCT00360217 · Maine Center for Lipids and Cardiovascular Health, Other · Completed
Key facts
| NCT number | NCT00360217 |
|---|---|
| Title | The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes |
| Official title | The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb) |
| Lead sponsor | Maine Center for Lipids and Cardiovascular Health, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hypertriglyceridemia (TG>200<500), Hyperlipidemia, Coronary Artery Disease, Coronary Risk Equivalent, Diabetes |
| Intervention type | Drug |
| Interventions | docosahexanoic acid (DHA) |
| Enrollment | 60 |
| Start date | Jan 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Aug 4, 2006 |
| Last update posted | Nov 18, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: